Probing the parallel resolution of Mosher's acid using a combination of quasi-enantiomeric oxazolidin-2-ones

Tetrahedron Asymmetry

Volumn 19, Issue 10, 2008, Pages 1274-1284

  Chavda, Sameer ^a   Coulbeck, Elliot ^a   Dingjan, Marco ^b   Eames, Jason ^a   Motevalli, Majid ^b  

^a UNIVERSITY OF HULL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHOXY 2 PHENYL 2 TRIFLUOROMETHYL ACETIC ACID; 2 METHOXY 2 PHENYL 2 TRIFLUOROMETHYLACETIC ACID; 2 PHENYL 2 METHOXY 2 TRIFLUOROETHANONYL)(2 ((BUTOXYCARBONYL)OXY) 2,2 DIPHENYL 2 PHENYLETHYL)CARBAMATE; 4 PHENYL 3 (2 METHOXY 2 PHENYL 2 TRIFLUOROMETHYLACETYL)OXAZOLIDIN 2 ONE; 4 PHENYL 5,5 DIPHENYL 3 (2 METHOXY 2 PHENYL 2 TRIFLUOROMETHYLACETYL)OXAZOLIDIN 2 ONE; ACETIC ACID; BUTYL 2 METHOXY 2 PHENYL 2 TRIFLUOROMETHYL ACETATE; N (2 HYDROXY 1 PHENYLETHYL) 2 PHENYL 2 METHOXY 2 TRIFLUOROMETHYLACETAMIDE; OXAZOLIDIN 2 ENONE; OXAZOLIDINE DERIVATIVE; PENTAFLUOROPHENYL 1 TRIFLUOROMETHYL 1 METHOXY PHENYLACETATE;

ARTICLE; CHEMICAL STRUCTURE; CRYSTAL STRUCTURE; ENANTIOMER; HYDROLYSIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SYNTHESIS;

EID: 44449137422     PISSN: 09574166     EISSN: 1362511X     Source Type: Journal    
DOI: 10.1016/j.tetasy.2008.04.032     Document Type: Article

References (65)

1. Alper H., and Hamel N. J. Am. Chem. Soc. 112 (1990) 2803-2804
2. Piccolo O., Spreafico F., Visentin G., and Valoti E. J. Org. Chem. 50 (1985) 3945-3946
3. Piccolo O., Azzena U., Melloni G., Delogu G., and Valoti E. J. Org. Chem. 56 (1991) 183-187
4. Ohta T., Takaya H., Kitamura M., Nagai K., and Noyori R. J. Org. Chem. 52 (1987) 3174-3176
5. Stille J.K., and Parrinello G. J. Mol. Catal. 21 (1983) 203-210
6. Kumar A., Salunkhe R.V., Rane R.A., and Dike S.Y. J. Chem. Soc., Chem. Commun. (1991) 485-486
7. Franck A., and Ruchardt C. Chem. Lett. (1984) 1431-1434
8. Prasad K.R., and Chandrakumar A. Tetrahedron: Asymmetry 16 (2005) 1897-1900
9. Moreno-Dorado F.J., Guerra F.M., Ortega M.J., Zubia E., and Massanet G.M. Tetrahedron: Asymmetry 14 (2003) 503-510
10. Sonawane H.R., Bellur N.S., Ahuja J.R., and Kulkarni D.G. Tetrahedron: Asymmetry 3 (1992) 163-192
11. Fuji K., Node M., Tanaka F., and Hosoi S. Tetrahedron Lett. 30 (1989) 2825-2828
12. Corriu J.P., and Masse J.P. J. Chem. Soc., Chem. Commun. (1972) 144-145
13. Tamao K., Sumitani K., and Kumada M. J. Am. Chem. Soc. 94 (1972) 4374-4379
14. Hayashi T., Konishi M., Fukushima M., Kanehira K., Hioki T., and Kumada M. J. Org. Chem. 48 (1983) 2195-2202
15. Larsen R.D., Corley E.G., Davis P., Reider P.J., and Grabowski E.J.J. J. Am. Chem. Soc. 111 (1989) 7650-7651
16. Huang H.-R., Xu J.-H., Xu Y., Pan J., and Liu X. Tetrahedron: Asymmetry 16 (2005) 2113-2117
17. Tanaka K., Fukuoka T., and Shiro M. J. Chem. Res. (S) (2002) 446-447
18. Mateo C., Chmura A., Rustler S., van Rantwijk F., Stolz A., and Sheldon R.A. Tetrahedron: Asymmetry 17 (2006) 320-323
19. Bew S.P., Davies S.G., and Fukuzawa S.-I. Chirality 12 (2000) 483-487
20. Nerurkar S.G., Dighe S.V., and Williams R.L. J. Clin. Pharmacol. 32 (1992) 935-943
21. For some recent examples, see:. Blay G., Fernandez I., Monje B., Munoz M.C., Pedro J.R., and Vila C. Tetrahedron 62 (2006) 9174-9182
22. Blay G., Fernandez I., Monje B., Munoz M.C., Pedro J.R., and Vila C. Tetrahedron 62 (2006) 8069-8076
23. Lee Y.J., Lee K., Jung S.I., Jeon H.B., and Kim K.S. Tetrahedron 61 (2005) 1987-2001
24. For reviews see:. Eames J. Angew. Chem., Int. Ed. 39 (2000) 885-888
25. Eames J. Organic Synthesis Highlights Vol. v, Chapter 17 (2003), VCH-Wiley pp 151-164
26. Dehli J.R., and Gotor V. Chem. Soc. Rev. 31 (2002) 365-370
27. Dehli J.R., and Gotor V. ARKIVOC v (2002) 196-202
28. Coumbarides G.S., Dingjan M., Eames J., Flinn A., Northen J., and Yohannes Y. Tetrahedron Lett. 46 (2005) 2897-2902
29. Coumbarides G.S., Dingjan M., Eames J., Flinn A., Motevalli M., Northen J., and Yohannes Y. Synlett (2006) 101-105
30. Coumbarides G.S., Dingjan M., Eames J., Flinn A., and Northen J. Chirality 19 (2007) 321-328
31. Chavda S., Coumbarides G.S., Dingjan M., Eames J., Flinn A., and Northen J. Chirality 19 (2007) 313-320
32. Dale J.A., Dull D.L., and Mosher H.S. J. Org. Chem. 34 (1969) 2543-2549
33. Evans D.A., Ennis M.D., and Mathre D.J. J. Am. Chem. Soc. 104 (1982) 1737-1739
34. Evans D.A. Aldrichim. Acta 15 (1982) 23-32
35. Evans D.A., Bartroli J., and Shih T.L. J. Am. Chem. Soc. 103 (1981) 2127-2129
36. Hintermann T., and Seebach D. Helv. Chim. Acta 81 (1998) 2093-2126
37. Gaul C., Schweizer B., Seiler P., and Seebach D. Helv. Chim. Acta 85 (2002) 1546-1566
38. The (R)- and (S)-enantiomer of active ester 10 can be synthesised in 92% and 88%, respectively.
39. The data relating to the single crystal X-ray structures of (R)-10 has been deposited at the Cambridge Crystallographic Database {CCDC reference number 683188}.
40. The absolute configurations of each diastereoisomer were assigned by stereospecific synthesis; see Section 4 for details.
41. Eames J., Boyd E., Chavda S., Eames J., and Yohannes Y. Tetrahedron: Asymmetry 18 (2007) 476-482
42. The configurational assignment was determined through stereospecific synthesis.
43. Boyd E., Chavda S., Coulbeck E., Coumbarides G.S., Dingjan M., Eames J., Flinn A., Motevalli M., Northen J., and Yohannes Y. Tetrahedron: Asymmetry 18 (2007) 2515-2530
44. An equimolar amount of (R)-4-Li and rac-13 gave the corresponding adduct (S,R)-syn-14 in 48% yield with 60% de (reported in Yohannes, Y. PhD Thesis, University of London, 2004).
45. 1H NMR spectroscopy.
46. Kroutil W., Kleewein A., and Faber K. Tetrahedron: Asymmetry 8 (1997) 3263-3274
47. Majeric M., and Sunjic V. Tetrahedron: Asymmetry 7 (1996) 815-824
48. Caron G., and Kazlauskas R.J. Tetrahedron: Asymmetry 4 (1993) 1995-2000
49. Brown S.M., Davies S.G., and Desousa J.A.A. Tetrahedron: Asymmetry 4 (1993) 813-822
50. Brown S.M., Davies S.G., and Desousa J.A.A. Tetrahedron: Asymmetry 2 (1991) 511-514
51. Chen C.S., and Liu Y.C. J. Org. Chem. 56 (1991) 1966-1968
52. Schreiber S.L., Schreiber T.S., and Smith D.B. J. Am. Chem. Soc. 109 (1987) 1525-1529
53. The low recoverability of the oxazolidinone (S)-9 was due to its insoluble nature.
54. Davies S.G., Doisneau G.J.-M., Prodger J.C., and Sanganee H.J. Tetrahedron Lett. 35 (1994) 2369-2372
55. Davies S.G., Doisneau G.J.-M., Prodger J.C., and Sanganee H.J. Tetrahedron Lett. 35 (1994) 2373-2376
56. Davies S.G., and Sanganee H.J. Tetrahedron: Asymmetry 6 (1995) 671-674
57. For a comprehensive account of endo-cleavage of 4-alkyl substituted-5,5-dimethyl-oxazolidin-2-ones (known as SuperQuats) see:. Davies S.G., Hunter I.A., Nicholson R.L., Roberts P.M., Savory E.D., and Smith A.D. Tetrahedron: Asymmetry 60 (2004) 7553-7577
58. Davies S.G., Nicholson R.L., and Smith A.D. Org. Biomol. Chem. 2 (2004) 3385-3400
59. 2 prior to use.
60. 1H NMR spectroscopy.
61. Campbell J.A., Lee W.K., and Rapport H. J. Org. Chem. 60 (1995) 4602-4616
62. The enantiomeric excess was determined by DCC coupling with either (R)- or (S)-1-phenylethanol.
63. Moreno-Dorado F.J., Guerra F.M., Ortega M.J., Zubia E., and Massanet G.M. Tetrahedron: Asymmetry 14 (2003) 503-510
64. Givens R.S., Chae W.K., and Matuszewski B. J. Am. Chem. Soc. 104 (1982) 2456-2466
65. Benson S.C., Cai P., Colon M., Haiza M.A., Tokles M., and Snyder J.K. J. Org. Chem. 53 (1988) 5335-5341